SPLEEN
Moderate-to-severe splenomegaly due to reticuloendothelial hypertrophy and hyperplasia is a common and often the only imaging finding. Hepatomegaly generally is not a prominent feature. A number of CT and US techniques have been developed to measure splenic volume. These are useful in patients with Gaucher’s disease who often undergo serial follow-up studies. Follow-up of splenic volume changes are best obtained using the same imaging modality.
A minority of patients have well-defined homogeneous hypodense nodules scattered throughout the spleen. Ultrasonography shows variable echogenicity in these nodules.An irregular, inhomogeneous appearance is seen if these nodules become confluent. Of interest is that splenectomized patients tend to develop retroperitoneal or periportal lymphadenopathy. Magnetic resonance imaging also identifies splenic nodules in some of these patients, with these nodules being isointense on T1and hypointense on T2-weighted images. Also, MR detects splenic infarcts in these patients.
These patients have decreased plasma levels of low-density lipoproteins. Technetium-99m– low-density lipoprotein scintigraphy shows that these proteins are taken up by the spleen, bone marrow, and liver reticuloendothelial system
(3). Such serial studies appear of value in follow-up after therapy.
Splenectomy and heterotopic splenic autotransplantation have been used to treat hypersplenism. Partial splenectomy often leads to enlargement of the splenic remnant. It is not clear if such enlargement is due to splenic tissue regeneration or continued glycolipid deposition or both.
An occasional patient with massive splenomegaly develops a splenic abscess.
Thalassemia
Hypersplenism can be corrected in children with thalassemia by partial or total surgical splenectomy. An alternative is partial splenic embolization. After embolization the spleen decreases in size and fewer transfusions are necessary.
Hereditary Spherocytosis
Patients with hereditary spherocytosis have hemolysis, either compensated or leading to anemia, and are at increased risk for bilirubinate gallstones, erythroid aplasia, and hemolytic crises.
Therapy consists of splenectomy, although partial splenic embolization is an option (4).
Niemann-Pick Disease
Niemann-Pick type C disease is an autosomalrecessive lipid storage disorder, leading to an accumulation of syringomyelin and cholesterol in the brain, liver, and spleen. Most affected patients develop neurologic symptoms. Isolated nodular splenomegaly develops in this condition.
Sickle Cell Disease
Patients with sickle cell disease are at risk for splenic infection, abscess, acute splenic sequestration crisis, hypersplenism, and splenic infarction. Most acute infarctions involve only a portion of the spleen, although total splenic infarction does develop. During an acute sequestration crisis the hematocrit drops and spleen enlarges, at times massively. Computed tomography identifies multiple hypodense foci in the spleen. Multiple episodes of focal splenic infarction eventually result in a small spleen, at times containing calcifications.
In patients homozygous for this condition MRI reveals a signal void on T2-weighted sequences due to a combination of iron deposition and superimposed calcifications (iron overload is discussed in Chapter 7). These patients have impairment of splenic reticuloendothelial function; scintigraphy with Tc- 99m–sulfur colloid reveals nonvisualization of the spleen.
Patients with sickle cell disease develop round intrasplenic nodules, shown to represent functioning splenic tissue; this tissue is hypodense on CT, hypoechoic on US, appears as normal spleen on MRI, and manifests uptake of Tc-99m–sulfur colloid. Imaging thus allows distinguishing these nodules from abscesses and infarcts.